ANTREP HEALTHCARE SOLUTIONS

PRODUCTS

  • Early stage cancer detection
    Company Biosysion UK (Biosysion Pvt Ltd)
  • We believe that early detection is key to overcoming cancer and other critical diseases. By detecting diseases at their earliest stages, we can empower healthcare providers to intervene earlier, when treatment is most effective, and improve patient outcomes. Our diagnostic tests are designed to detect diseases with unparalleled sensitivity and accuracy, enabling early intervention and personalized treatment approaches.

 

  • AHS and its principal Biosysion, offer a comprehensive portfolio of diagnostic tests and assays for a wide range of diseases, including cancer, infectious diseases, cardiovascular disorders, and genetic conditions
  • Quality, accuracy, and reliability are at the heart of everything Biosysion does . We adhere to the highest standards of quality control, regulatory compliance, and ethical conduct to ensure that our diagnostic solutions meet the needs of healthcare providers and patients worldwide. Our commitment to excellence drives us to continuously innovate and improve, pushing the boundaries of what is possible in molecular diagnostics

Colocam DX – FIT Tube

  • ColoCam Tube® -is most advanced non-invasive Fecal Immunochemical Test that is reliable, accurate, and affordable.
  • FIT colon cancer screening test is a proven and recommended colon cancer screening test used by doctors and hospitals worldwide – over-the-counter self-test kit.
  • The ColoCam Tube® self-test is easy to perform in the comfort of your own home and results are ready within five minutes.
  • With ColoCam Tube®, no prescription, doctors visit, or mailing a sample back to a laboratory is required.

ColoCam DX – FIT DNA

  • Colorectal cancer begins when cells in the intestine undergo genetic mutations. Tumor cells shed into the intestines. Stool samples can be examined for tumor DNA using PCR technology.
  • Polymerase chain reaction (PCR) is used to rapidly make millions to billions of copies of a specific DNA sample and only requires a very small sample of DNA to amplify it large enough for detailed study.
  • ColoCam DX® utilizes proprietary methods to analyse the cell DNA for specific tumor markers.
  • ColoCam DX® is designed to detect tumor DNA and detect 95% of colorectal cancer cases – often in the earliest stages of the disease.*
  • Ease-of-use drives ongoing patient adherence as the ColoCam DX® method requires very small samples compared to screening method